<html><head><title>2024-01-17</title><link rel="stylesheet" type="text/css" href="static/table.css"/></head><body><table id="container">
  <thead>
    <tr style="text-align: right;">
      <th role="columnheader">No.</th>
      <th role="columnheader">capSize</th>
      <th role="columnheader">stock</th>
      <th role="columnheader">chance</th>
      <th role="columnheader">risk</th>
      <th role="columnheader">tags</th>
      <th role="columnheader">Volatility</th>
      <th role="columnheader">YTD%</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>1</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/MRK">MRK<br>Merck &</a></td>
      <td>1. FDA approval for Keytruda in combination with chemoradiotherapy for cervical cancer is a significant positive development for Merck & Co., Inc.<br>2. Merck Animal Health's positive trend in veterinarian practices and mental health underscores the company's commitment to animal health and wellbeing.<br>3. The approval of Keytruda plus chemoradiotherapy as a first anti-PD-1-based immunotherapy combination for certain type of cervical cancer patients positions Merck as a leader in the oncology space.</td>
      <td>1. Insiders at Merck & Co., Inc. have been selling their stock over the past year, which may raise concerns about the company's future performance.<br>2. Competition in the obesity space and entry of several big pharma companies may pose a risk to Merck's market share.</td>
      <td>FDA Approval<br>Keytruda<br>Animal Health<br>Oncology<br>Competition</td>
      <td>242.99</td>
      <td>16.08</td>
    </tr>
    <tr>
      <td>2</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/PAGS">PAGS<br>PagSeguro Digital</a></td>
      <td>1. PagSeguro (PAGS) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.<br>2. Brazil-focused fintechs, including PagSeguro, are thriving amid a strong economy, internet user growth and the unbanked.<br>3. PagSeguro Digital Ltd. (PAGS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.</td>
      <td>1. Technology stocks faced a heavy beat down in 2022 and were one of the worst-performing sectors of the year.<br>2. Over the last month the PagSeguro Digital Ltd. ( NYSE:PAGS ) has been much stronger than before, rebounding by 40%.</td>
      <td>Fintech<br>Brazil<br>Earnings<br>Tech Stocks<br>Investment</td>
      <td>233.83</td>
      <td>74.29</td>
    </tr>
    <tr>
      <td>3</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/KO">KO<br>nan</a></td>
      <td>1. Coca-Cola (KO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.<br>2. Coca-Cola pays an above-average dividend, and its status as a Dividend King gives assurance the payouts will continue.<br>3. The company's strategic pricing actions and the craft beer experience offered by Boston Beer (SAM) have helped maintain its premium position in the market.</td>
      <td>1. Coca-Cola (KO) underperformed the market last year, indicating potential market challenges.<br>2. Institutional holdings in Coca-Cola imply significant influence, which could expose the company to external factors beyond its control.</td>
      <td>Beverage Industry<br>Dividend Income<br>Earnings Surprise<br>Market Performance<br>Risk Management</td>
      <td>364.24</td>
      <td>5.93</td>
    </tr>
    <tr>
      <td>4</td>
      <td>Large</td>
      <td><a href="https://xueqiu.com/S/SHOP">SHOP<br>Shopify</a></td>
      <td>1. The e-commerce enabler made a substantial strategic mistake but managed to bounce back from the consequences.<br>2. Some skyrocketing stocks are poised to keep rising for a long time, making money for investors along the way.<br>3. Monster and Shopify look poised for bull runs in the new year.<br>4. Manhattan Associates (MANH) and Shopify team up to help retailers deliver better shopping experiences.<br>5. The deal expands Rokt's client portfolio to more than 20,000 SMB merchants and brings AI technology to small businesses, enhancing the Rokt Ecommerce app's capabilities.</td>
      <td>1. DZ Bank downgraded Shopify (NYSE:SHOP) to Sell from Hold with a price target of $65.00 (from $62.00)<br>2. Has the e-commerce giant's stock run out of steam?<br>3. Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: downgrades at Shopify, Snowflake, Nutrien, and Illumina.<br>4. Etsy underperformed its peers in 2023.</td>
      <td>E-commerce<br>Stock Analysis<br>Retail<br>Market Momentum</td>
      <td>291.15</td>
      <td>36.21</td>
    </tr>
    <tr>
      <td>5</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/CSCO">CSCO<br>Cisco Systems</a></td>
      <td>1. Technology is transforming our lives, changing the way we learn, work, interact with others and get access to all types of services.<br>2. Cisco is committed to fostering an inclusive future for all and is addressing the digital divide through research collaborations.<br>3. Cisco Foundation's climate investment strategy is fueled by conviction in Africa's vast potential.</td>
      <td>1. Cisco has seen some negative news from analysts recently.<br>2. Cisco faces competition from other companies like Hewlett Packard Enterprise, Juniper Networks, Cisco, and Arista.</td>
      <td>Technology<br>Inclusive future<br>Research collaboration<br>Competition<br>Digital divide</td>
      <td>284.66</td>
      <td>-3.38</td>
    </tr>
    <tr>
      <td>6</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/TME">TME<br>Tencent Music Entertainment</a></td>
      <td>1. Tencent Music Entertainment Group has renewed a multi-year strategic licensing agreement with Universal Music Group, demonstrating a strong commitment to creating value for artists and exceptional experiences for music lovers.<br>2. The company's stock may see a positive impact as music streaming stocks are anticipated to rise steadily in the future, with many of them having great future prospects.<br>3. Tencent Holdings Limited, the parent company of TME, posted impressive third quarter results, showing a rebound in the gaming segment and shining advertising sales.</td>
      <td>1. The resignation of TME's Group Vice President and other relevant roles may have an impact on the company's operations and leadership.<br>2. The company may face regulatory challenges in the Chinese market, as evidenced by the rebound from China’s tech regulatory crackdown.<br>3. The stock's performance may be influenced by the overall market and industry trends in the media and music streaming segments.</td>
      <td>Music Streaming Stocks<br>Regulatory Challenges<br>Strategic Licensing Agreement<br>Market Trends<br>Leadership Changes</td>
      <td>248.31</td>
      <td>24.10</td>
    </tr>
    <tr>
      <td>7</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/ETRN">ETRN<br>Equitrans Midstream</a></td>
      <td>1. Equitrans Midstream is setting up just below a buy point amid a run of more than 50% in 2023.<br>2. Operational results for the third quarter of 2023 show a 12% transmission pipeline throughput growth.<br>3. Equitrans Midstream delivered earnings and revenue surprises of 75% and 1.51%, respectively, for the quarter ended September 2023.</td>
      <td>1. The company was in the early stages of considering a sale, which could impact stock performance.<br>2. Falling U.S. natural gas prices may present a risk to the company’s performance.</td>
      <td>Oil and Gas<br>Midstream Services<br>Pipeline Operations<br>Stock Analysis<br>Market Performance</td>
      <td>320.09</td>
      <td>15.93</td>
    </tr>
    <tr>
      <td>8</td>
      <td>Mega</td>
      <td><a href="https://xueqiu.com/S/ORCL">ORCL<br>Oracle</a></td>
      <td>1. Oracle Corp. has been recognized as a Leader in the 2023 Gartner Magic Quadrant for Cloud Database Management Systems, showcasing its strong position in the cloud database market.<br>2. The company's introduction of new capabilities to Oracle Fusion Cloud Enterprise Performance Management, in partnership with Deloitte, demonstrates its commitment to innovation and addressing evolving tax requirements for multinational organizations.</td>
      <td>1. There are short-term question marks investors should consider before investing, indicating potential uncertainties in the near future.<br>2. While the company has a strong dividend history and yield, there may be risks associated with its operations and market conditions that could impact its performance.</td>
      <td>Cloud Database Management Systems<br>Innovation<br>Tax Compliance<br>Market Uncertainties<br>Dividend Performance</td>
      <td>508.63</td>
      <td>0.09</td>
    </tr>
    <tr>
      <td>9</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/FTNT">FTNT<br>Fortinet</a></td>
      <td>1. Fortinet (FTNT) has been gaining attention from investors and analysts, indicating potential for growth in the stock's prospects.<br>2. The announcement of the industry’s only integrated secure networking solution with Wi-Fi 7 and the launch of a new access point and 10 Gigabit Power over Ethernet switch demonstrates Fortinet's commitment to innovation and staying ahead in the cybersecurity market.<br>3. The company's collaboration with global leaders and experts to offer strategic counsel on fundamental principles driving trust shows its dedication to staying at the forefront of the cybersecurity landscape.</td>
      <td>1. Investors need to consider the potential risks associated with investing in the cybersecurity sector, including market volatility, regulatory changes, and increasing competition.<br>2. The fluctuation in the stock price and the uncertainty in the broader market could pose risks for potential investors in Fortinet (FTNT).<br>3. The cybersecurity industry is constantly evolving, and Fortinet may face challenges in keeping up with emerging cyber threats and technological advancements.</td>
      <td>Cybersecurity<br>Innovation<br>Market volatility<br>Competition<br>Strategic collaboration</td>
      <td>403.29</td>
      <td>7.66</td>
    </tr>
    <tr>
      <td>10</td>
      <td>Large</td>
      <td><a href="https://xueqiu.com/S/UBER">UBER<br>Uber</a></td>
      <td>1. Uber's exclusive purchase incentives for Tesla's Model 3 and Model Y could boost driver adoption of electric vehicles and reduce operating costs.<br>2. Uber's decision to shut down alcohol delivery platform Drizly reflects a strategic shift towards focusing on the core Uber Eats business.<br>3. The closure of Drizly could streamline Uber's operations and potentially improve overall efficiency.<br>4. The Zacks Focus List offers users an opportunity to identify top-rated stocks, signaling a positive sentiment towards Uber's stock.<br>5. Uber's decision to discontinue Drizly may lead to cost savings and better utilization of resources.</td>
      <td>1. Closure of Drizly could result in loss of revenue and potential impact on overall business performance.<br>2. The decision to focus solely on Uber Eats could lead to increased competition with other food delivery platforms.<br>3. Investors may view the shutdown of Drizly as a negative signal, potentially impacting Uber's stock performance.<br>4. Uber's exclusive purchase incentives for Tesla vehicles may not be enough to overcome the initial cost barrier for drivers.<br>5. The closure of Drizly could cause disruption and upset existing customers, leading to potential brand damage.</td>
      <td>Uber<br>Technology<br>Ride-sharing<br>Food delivery<br>Business strategy</td>
      <td>934.30</td>
      <td>36.94</td>
    </tr>
    <tr>
      <td>11</td>
      <td>Large</td>
      <td><a href="https://xueqiu.com/S/PFE">PFE<br>Pfizer</a></td>
      <td>1. Pfizer CEO is 'all in' on Pfizer stock, showing confidence in the company's future<br>2. Pharmaceutical executives from various companies are looking to break into the lucrative obesity market, indicating potential for industry growth<br>3. Pfizer is receiving unsolicited mini-tender offers, suggesting interest from potential investors</td>
      <td>1. Pfizer's best days might be behind it as demand for its COVID-19 products slows down<br>2. Pfizer shares dropped more than 40% last year, indicating potential instability in the stock<br>3. Legal battles against diversity and inclusion programs could impact Pfizer's image and operations</td>
      <td>Pharmaceutical<br>Investment<br>Stock<br>Market Growth<br>Legal Issues</td>
      <td>264.44</td>
      <td>-5.88</td>
    </tr>
    <tr>
      <td>12</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/BTI">BTI<br>nan</a></td>
      <td>1. Despite the decline in revenue at the Marlboro maker, high-yield dividend stocks are trading at bargain-bin prices, providing potential for a good entry point for investors.<br>2. The ongoing roller-coaster in the market presents an opportunity for resilience and strategic prowess across divergent industries, including the tobacco sector.</td>
      <td>1. The decline in revenue at the Marlboro maker and the uncertainty of the market could pose risks for potential investors.<br>2. The U.S. Supreme Court's decision not to hear R.J. Reynolds Tobacco Company's challenge to California's flavored tobacco ban may impact the company's future prospects.</td>
      <td>high-yield dividend stocks<br>market uncertainty<br>tobacco sector resilience<br>legal challenges<br>revenue decline</td>
      <td>313.20</td>
      <td>-0.90</td>
    </tr>
    <tr>
      <td>13</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/ET">ET<br>nan</a></td>
      <td>1. Energy Transfer LP (ET) has shown resilience in the face of market fluctuations and has a growing distribution, offering a 9% yield</td>
      <td>1. The energy market is volatile and subject to geopolitical and economic factors that can impact the performance of ET</td>
      <td>Energy sector<br>MLP and Pipeline Stocks<br>Oil stocks<br>Natural gas dividend stocks<br>Market resilience</td>
      <td>518.64</td>
      <td>1.91</td>
    </tr>
    <tr>
      <td>14</td>
      <td>Small</td>
      <td><a href="https://xueqiu.com/S/QS">QS<br>QuantumScape</a></td>
      <td>1. QuantumScape is trying to address a big point of hesitancy from potential EV customers.<br>2. The EV battery maker just got good news about its solid-state battery. Is it a buy?<br>3. It has a pretty big lead over others developing solid-state batteries. But that doesn't promise it will be a winner.</td>
      <td>1. A report suggests QuantumScape's key partner could be looking for other sources of solid-state batteries.<br>2. Volkswagen, QuantumScape's key partner, is holding talks with another company for solid-state batteries.<br>3. There are a lot of risks with this battery technology stock, but also a lot of potential upside.</td>
      <td>Energy Storage<br>Electric Vehicles<br>Solid-State Batteries<br>Technology<br>Innovation</td>
      <td>222.97</td>
      <td>7.70</td>
    </tr>
    <tr>
      <td>15</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/NOK">NOK<br>Nokia</a></td>
      <td>1. Nokia plans to invest €360 million in software, hardware and chip design at its Ulm and Nuremberg sites, showing commitment to technological advancements and innovation.<br>2. The launch of Nokia Federal Solutions (NFS) demonstrates Nokia's dedication to delivering secure and innovative solutions to the U.S. federal government, indicating potential growth opportunities in the government sector.<br>3. Nokia's strong patent portfolio and successful licensing deals reflect the inherent strength and potential revenue generation of its intellectual property, presenting a positive outlook for future earnings.<br>4. Nokia's agreement with Honor and its significant patent portfolio emphasize the company's strategic position in 5G technologies and potential for royalty revenue, highlighting its competitive advantage in the industry.</td>
      <td>1. Missed financial targets and delayed license renewals in the Nokia Technologies segment may impact the company's fiscal performance and revenue recognition, presenting potential challenges in meeting financial expectations.<br>2. Legal disputes with Chinese device makers over patents could lead to prolonged litigation, potential legal expenses, and uncertainty regarding the resolution of these disputes, posing risks to the company's financials and market positioning.<br>3. Fluctuations in stock price and potential market volatility may impact investor confidence and stock performance, leading to uncertainty in shareholder returns and portfolio valuation.<br>4. Currency exchange rates and geopolitical developments may influence Nokia's international operations and revenue generation, presenting potential risks associated with global economic and political factors.</td>
      <td>Investment<br>Technology<br>Government Sector<br>Patent Portfolio<br>Market Positioning</td>
      <td>335.35</td>
      <td>4.78</td>
    </tr>
    <tr>
      <td>16</td>
      <td>Middle</td>
      <td><a href="https://xueqiu.com/S/MRNA">MRNA<br>Moderna</a></td>
      <td>1. Moderna's product pipeline includes a wide range of modalities, such as prophylactic vaccines, cancer vaccines, and localized regenerative therapeutics, providing opportunities for significant future growth.<br>2. The company's focus on intratumoral immuno-oncology and systemic intracellular therapeutics reflects a strong commitment to addressing complex medical challenges with innovative solutions.<br>3. Moderna's reported product sales of $6.7 billion for 2023, meeting its previously issued guidance, indicate a strong revenue performance, which could positively impact the stock's valuation.<br>4. The company's shift towards fighting cancer, along with the development of a cancer vaccine, shows a strategic response to evolving market demands and positions Moderna for potential success in this therapeutic area.<br>5. The S&P 500's proximity to entering official bull market territory could provide a favorable market environment for Moderna's stock to gain momentum and potentially experience a positive price trend.</td>
      <td>1. Moderna's stock has experienced significant volatility in response to factors such as overall vaccine sales, and weak sales performance has resulted in a substantial decline in its stock price over the last year.<br>2. The company's heavy focus on mRNA-based medicines carries the risk of potential regulatory, technological, and market acceptance challenges, which could impact the success of its product pipeline.<br>3. The competition in the biotech sector is intense, and Moderna faces the risk of market share erosion and pricing pressures from established pharmaceutical companies and emerging biotech startups.<br>4. Moderna's 2024 outlook and approach to returning to sales growth in 2025 need to be carefully monitored, as any setbacks in achieving these targets could negatively influence investor confidence and the stock's performance.<br>5. The company's reliance on the success of its cancer vaccine and other novel therapeutic modalities makes it susceptible to clinical trial outcomes, regulatory approvals, and market adoption, all of which represent inherent risks.</td>
      <td>Biotech<br>mRNA Medicines<br>Cancer Vaccines<br>Market Performance<br>Volatility</td>
      <td>307.42</td>
      <td>43.42</td>
    </tr>
  </tbody>
</table><script src="static/tablesort.min.js"></script><script src="static/tablesort.number.min.js"></script><script>new Tablesort(document.getElementById("container"));</script></body></html>